Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
Steno launches AI-powered transcript analysis tool, Transcript Genius, empowering legal professionals with unlimited and customizable summaries, in-depth deposition analysis capabilities and more. Los ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results